The Department of Health and Social Care (DHSC) today announced the removal of Alogliptin from the list of medicines which cannot be parallel-exported from the UK.
The restrictions are removed with immediate effect, according to the government department.
The government first announced a ban on parallel export of 23 types of medical devices and drugs, including oral anti-diabetic drug Alogliptin, in October and later added 11 more to the list.
The list currently includes Adrenaline auto-injectors, Hepatitis B vaccine, Hepatitis B (rDNA) suspension injection, Misoprostol, Pneumococcal Polysaccharide vaccine, and Hepatitis A and B vaccine.
Any manufacturer or wholesaler found guilty of parallel-exporting one or more of the listed medicines could face immediate licence suspension.